Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03TAY
|
|||
| Former ID |
DNCL003300
|
|||
| Drug Name |
VGX-3400
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Influenza A virus H5N1 infection [ICD-11: 1E30] | Phase 1 | [1] | |
| Company |
Inovio Pharmaceuticals
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Influenza Hemagglutinin (Influ HA) | Target Info | . | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01142362) Study of VGX-3400X, H5N1 Avian Influenza Virus DNA Plasmid + Electroporation in Healthy Adults. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Inovio Pharmaceuticals. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.